Hille Vax, Inc. HLVX
Institutional shares held
39 Million
0
calls
0
puts
Total value of holdings
$618M
$0
calls
$0
puts
Market Cap
$529M
33,427,200
Shares Out.
Institutional ownership
116.63%
# of Institutions
82
We take great care to ensure that the data presented and summarized in this overview for HilleVax, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HLVX
View all-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.78MShares$155 Million8.54% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4MShares$63.4 Million1.38% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.06MShares$48.5 Million0.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT2.57MShares$40.7 Million1.41% of portfolio
-
Vr Adviser, LLC New York, NY2.08MShares$32.9 Million2.96% of portfolio
-
Franklin Resources Inc San Mateo, CA1.85MShares$29.4 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC1.84MShares$29.1 Million2.25% of portfolio
-
Abingworth LLP London, X01.84MShares$29.1 Million10.2% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.36MShares$21.6 Million0.0% of portfolio
Latest Institutional Activity in HLVX
Top Purchases
Top Sells
About HLVX
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Insider Transactions at HLVX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
723
-0.09%
|
$10,122
$14.15 P/Share
|
|
May 02
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.76%
|
$84,000
$14.01 P/Share
|
|
May 01
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
175
-0.02%
|
$2,450
$14.03 P/Share
|
|
Apr 05
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.75%
|
$84,000
$14.44 P/Share
|
|
Apr 04
2024
|
Frazier Life Sciences X, L.P. |
BUY
Open market or private purchase
|
Direct |
8,850
+0.1%
|
$123,900
$14.5 P/Share
|
|
Apr 04
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.75%
|
$84,000
$14.71 P/Share
|
|
Apr 03
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.74%
|
$84,000
$14.93 P/Share
|
|
Mar 28
2024
|
Sean Mc Loughlin Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,250
+50.0%
|
$20,000
$16.98 P/Share
|
|
Mar 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.74%
|
$985,326,000
$164221.0 P/Share
|
|
Mar 19
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.73%
|
$102,000
$17.42 P/Share
|
|
Mar 18
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.73%
|
$102,000
$17.66 P/Share
|
|
Mar 08
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.72%
|
$108,000
$18.66 P/Share
|
|
Mar 07
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.72%
|
$108,000
$18.37 P/Share
|
|
Mar 06
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.71%
|
$108,000
$18.95 P/Share
|
|
Feb 22
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.71%
|
$90,000
$15.05 P/Share
|
|
Feb 21
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.7%
|
$84,000
$14.92 P/Share
|
|
Feb 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.7%
|
$84,000
$14.88 P/Share
|
|
Feb 12
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.69%
|
$90,000
$15.32 P/Share
|
|
Feb 08
2024
|
Aditya Kohli |
BUY
Grant, award, or other acquisition
|
Direct |
54,898
+5.95%
|
-
|
|
Feb 08
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
8,866
-1.08%
|
$124,124
$14.93 P/Share
|
Last 12 Months Summary
Buy / Acquisition
340K
Shares
From
6
Insiders
| Grant, award, or other acquisition | 330K shares |
|---|---|
| Open market or private purchase | 10.1K shares |
Sell / Disposition
168K
Shares
From
5
Insiders
| Open market or private sale | 158K shares |
|---|---|
| Sale (or disposition) back to the issuer | 10K shares |